Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis - Wikidata - wikimedia - TriplyDB

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

http://www.wikidata.org/entity/Q34145860

about

Hepatocellular carcinoma: Review of disease and tumor biomarkers Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas.Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models.Integrin α3β1 regulates kidney collecting duct development via TRAF6-dependent K63-linked polyubiquitination of Akt Cytosolic phospholipase A₂: physiological function and role in disease.A VE-cadherin-PAR3-α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A(2)α in endothelial cells.Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis.Cellular oxidative stress response mediates radiosensitivity in Fus1-deficient mice.Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival Calcium-dependent phospholipase A2 modulates infection-induced diaphragm dysfunction.Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.Cytosolic phospholipase A2 (cPLA2) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages.Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.Integrin alpha6 maintains the structural integrity of the kidney collecting system.Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib.Somatic mutations in arachidonic acid metabolism pathway genes enhance oral cancer post-treatment disease-free survival.The Quest for Relevant Hepatocellular Carcinoma Biomarkers.Presenilin Mutation Suppresses Lung Tumorigenesis via Inhibition of Peroxiredoxin 6 Activity and Expression.Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI.

P2860

Q26750796-9F957649-643F-4335-97F6-5890EBF372AC Q26997377-10704D79-4352-4852-AA9A-B86F3A230C3D Q33717695-DBCADE41-0542-4CBE-B679-921470D2F72F Q34099708-F2314D57-B228-4F2A-BE6A-A6CBAC10E279 Q34874275-9C3173B8-7381-4A4F-B86A-92CA707DE673 Q35621960-19765C6A-723D-4991-8714-A0E620155FEE Q35886245-87B717ED-30BD-48AC-8DAB-92A8B0509631 Q35917944-DE14B36F-4DB7-4A6C-9478-090B16491B86 Q35948220-D8B7401F-D5CD-44C7-AB22-3DD6856B990C Q36049513-2434FA3F-9460-47A9-A915-801818478A0C Q36347258-BF622A45-600A-4BED-8D61-37F8043759B0 Q36566768-28BD0AD0-4978-4A75-81B6-B6400EF8EE9E Q36976588-DFF32F86-84E2-4A54-B54F-E073A7EB2810 Q37031569-818BB692-2598-413A-BA67-D864DE37D7AB Q37178634-72070125-CFB7-45CA-BED9-D05633CC966F Q37885347-860CA24F-8220-4D48-B6C1-8744194581E3 Q38397273-B4551C6E-53EB-4BE4-A3CF-102D484E0D54 Q39043889-6C76BD95-40D5-4927-98B3-6D94E0E55EF4 Q39393558-6FD77767-2FC7-4FCA-9757-9F48351DC546 Q39410149-A02CBA25-01B3-4AED-A0C7-994A4D2FBC86 Q41679141-EB928346-FFE3-4795-8083-0752BCF7C897 Q42341394-66580D46-1C43-41F6-A810-D09667F54788 Q47122996-D4CBDCD3-9F07-4258-A187-258E797DEEB1 Q48196734-75224447-DD66-4A5D-B7AD-5056DF8CAACD

P2860

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

http://www.wikidata.org/entity/Q34145860

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@ast

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@en

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@nl

type

label

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@ast

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@en

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@nl

prefLabel

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@ast

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@en

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@nl

P1433

Q34145860-329A4FFC-1583-4C9A-9059-81C9D2270288

P1476

Q34145860-D2BE0A3E-F40B-4641-8253-F7559CCF4BA1

P2093

Q34145860-35C48D64-1419-46DB-85F2-D2D66DD95D64

Q34145860-B5627B89-2AAB-4A9F-925C-66DF542AE9C4

Q34145860-F81A34A5-4F07-4933-96B6-5A1C778622EC

P2860

Q34145860-0101A586-AFBA-44A1-8BEF-918D6451DDF4

Q34145860-07812629-1094-497B-B95F-44E6E9EF6A0A

Q34145860-0C73E52F-2F6F-40CD-B8C2-386D6D39B45A

Q34145860-0C826387-14F7-453B-BD80-9462ED5D1359

Q34145860-12BDE7A3-65E5-4588-8C74-90A39C9D65B1

Q34145860-15694C49-C921-40A6-BED3-838379A37061

Q34145860-19482EBA-E207-4627-A867-0A0949893E93

Q34145860-1A25CA51-7072-4683-95C5-C4978B7DE10E

Q34145860-1A7FC008-D674-4650-83B7-520568EEB969

Q34145860-1ACE7C34-D3F3-4A19-AE9C-9333AE7E03D5

P304

Q34145860-9A984E25-CF34-4257-A685-F707977E232B

P31

Q34145860-FA7B1E52-BFC2-41F4-82BB-B3777BB2156E

P356

Q34145860-40FE3299-771A-4664-9458-53F2AD39E7B5

P407

Q34145860-E909B2F9-CA72-41E7-AC72-6D5DC3122B41

P433

Q34145860-BD82866A-4B2A-4270-8325-EC57456BAFA1

P478

Q34145860-CD92D003-8F0D-4051-8E8C-512EC4F0FE70

P577

Q34145860-4E859942-E7A5-4EF4-B28E-034A4235CF02

P5875

Q34145860-47F5B429-20F0-47B9-9249-B24EB9AA585F

P698

Q34145860-810C9F5F-B20A-417E-8C95-E28CA90FE6CE

P932

Q34145860-A95B2060-C968-405E-A438-F983527177F1

P356

P1433

Journal of the National Cancer Institute

P1476

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis

@en

P2093

Amanda G Linkous

http://www.w3.org/2001/XMLSchema#string

Dennis E Hallahan

http://www.w3.org/2001/XMLSchema#string

Eugenia M Yazlovitskaya

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity

The role of pericytes in blood-vessel formation and maintenance

Tumor angiogenesis: therapeutic implications

Revisions in the International System for Staging Lung Cancer

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells

Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha.

The 85-kD cytosolic phospholipase A2 knockout mouse: a new tool for physiology and cell biology.

P304

1398-1412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJQ290

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45799899

http://www.w3.org/2001/XMLSchema#string

P698

20729478

http://www.w3.org/2001/XMLSchema#string

P932

2943523

http://www.w3.org/2001/XMLSchema#string